Literature DB >> 12203164

Prospective evaluation of a model of prediction of invasive bacterial infection risk among children with cancer, fever, and neutropenia.

M E Santolaya1, A M Alvarez, C L Avilés, A Becker, J Cofré, N Enríquez, M O'Ryan, E Payá, C Salgado, P Silva, J Tordecilla, M Varas, M Villarroel, T Viviani, M Zubieta.   

Abstract

A risk prediction model for invasive bacterial infection (IBI) was prospectively evaluated among children presenting with cancer, fever, and neutropenia. The model incorporated assessment of 5 previously identified risk factors: serum level of C-reactive protein (CRP) >/=90 mg/L, hypotension, identification of relapse of leukemia as the cancer type, platelet count of </=50,000 platelets/mm(3), and recent receipt of chemotherapy [16]. Children were uniformly evaluated at enrollment and were classified as having high or low risk for IBI according to a model that considers the number and type of variables present. Of the 263 febrile episodes evaluated during a 17-month period, 140 (53%) were in IBI-positive children. The sensitivity, specificity, and positive and negative predictive values of the model were 92%, 76%, 82%, and 90%, respectively. Identification of these 5 risk factors during the first 24 h of hospitalization was helpful in discriminating between children with a high or low risk for IBI.

Entities:  

Mesh:

Year:  2002        PMID: 12203164     DOI: 10.1086/342064

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  20 in total

1.  Outpatient treatment for people with cancer who develop a low-risk febrile neutropaenic event.

Authors:  Rodolfo Rivas-Ruiz; Miguel Villasis-Keever; Guadalupe Miranda-Novales; Osvaldo D Castelán-Martínez; Silvia Rivas-Contreras
Journal:  Cochrane Database Syst Rev       Date:  2019-03-19

2.  Impact of respiratory viral panel testing on length of stay in pediatric cancer patients admitted with fever and neutropenia.

Authors:  Kaitlin Shinn; Martha Wetzel; Nicholas P DeGroote; Frank Keller; Michael Briones; James Felker; Sharon Castellino; Tamara P Miller
Journal:  Pediatr Blood Cancer       Date:  2020-09-02       Impact factor: 3.167

3.  Evaluation of six risk factors for the development of bacteremia in children with cancer and febrile neutropenia.

Authors:  E J Asturias; J E Corral; J Quezada
Journal:  Curr Oncol       Date:  2010-04       Impact factor: 3.677

4.  Can complications in febrile neutropenia be predicted? Report from a developing country.

Authors:  Sapna Oberoi; Anirban Das; Amita Trehan; Pallab Ray; Deepak Bansal
Journal:  Support Care Cancer       Date:  2017-06-11       Impact factor: 3.603

5.  Development and validation of a prediction model for diagnosing blood stream infections in febrile, non-neutropenic children with cancer.

Authors:  Adam J Esbenshade; M Cecilia Di Pentima; Zhiguo Zhao; Ayumi Shintani; Jennifer C Esbenshade; Monique E Simpson; Kathleen C Montgomery; Robert B Lindell; Haerin Lee; Ato Wallace; Kelly L Garcia; Karel G M Moons; Debra L Friedman
Journal:  Pediatr Blood Cancer       Date:  2014-10-18       Impact factor: 3.167

Review 6.  Optimum management of pediatric patients with fever and neutropenia.

Authors:  Aditya H Gaur; Patricia M Flynn; Jerry L Shenep
Journal:  Indian J Pediatr       Date:  2004-09       Impact factor: 1.967

7.  Evaluation of a fever-management algorithm in a pediatric cancer center in a low-resource setting.

Authors:  Sheena Mukkada; Cristel Kate Smith; Delta Aguilar; April Sykes; Li Tang; Mae Dolendo; Miguela A Caniza
Journal:  Pediatr Blood Cancer       Date:  2017-09-12       Impact factor: 3.167

Review 8.  Systematic review and meta-analysis of the discriminatory performance of risk prediction rules in febrile neutropaenic episodes in children and young people.

Authors:  Bob Phillips; Ros Wade; Lesley A Stewart; Alex J Sutton
Journal:  Eur J Cancer       Date:  2010-11       Impact factor: 9.162

Review 9.  Platelets in defense against bacterial pathogens.

Authors:  Michael R Yeaman
Journal:  Cell Mol Life Sci       Date:  2009-12-15       Impact factor: 9.261

10.  Antibacterial effect of autologous platelet-rich gel derived from subjects with diabetic dermal ulcers in vitro.

Authors:  Lihong Chen; Chun Wang; Hengchuan Liu; Guanjian Liu; Xingwu Ran
Journal:  J Diabetes Res       Date:  2013-02-28       Impact factor: 4.011

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.